European Commission logo
Program

Optimising Advanced Therapy Medicinal Product (ATMP) Manufacturing

Funds industry-academia consortia that refine and scale up the manufacturing process for one class of cell or gene therapy, from quality control through to deployment.

The European Commission funds Innovation Action grants to consortia that demonstrate a faster, cheaper manufacturing process while holding product quality and standardisation steady. Applicants commit to first deployment of the improved process in the EU, and five awards are expected.

BiotechAdvanced ManufacturingMedtech

Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.